BLOG: High expectations for melanoma drug ipilimumab
I wrote about the cancer drug ipilimumab last year, which has been hailed as miraculous by some. The drug has been through Phase 3 clinical trials and results will be presented on June 6 at the annual meeting of the American Society of Clinical Oncology (ASCO). Meanwhile, following announcements of the miracle cure in three [...]
Read MoreMiracle prostate cancer drug not so miraculous?
The Mayo clinic reported over the weekend in its news section that two men with late-stage prostate cancer were successfully treated with a monoclonal antibody treatment (one of the most promising areas of research for cancer drugs) developed by Medarex Inc. Shares increased by 20% on Monday. An article by the AP pointed out at [...]
Read More